|
1.
|
D LiK XieR WolffJL AbbruzzesePancreatic
cancerLancet36310491057200410.1016/S0140-6736(04)15841-8
|
|
2.
|
TP YeoRH HrubanSD LeachPancreatic
cancerCurr Probl
Cancer26176275200210.1067/mcn.2002.12957912399802
|
|
3.
|
RA AbramsLB GrochowA
ChakravarthyIntensified adjuvant therapy for pancreatic and
periampullary adenocarcinoma: survival results and observations
regarding patterns of failure, radiotherapy dose and CA19-9
levelsInt J Radiat Oncol Biol
Phys4410391046199910.1016/S0360-3016(99)00107-8
|
|
4.
|
DK PleskowHJ BergerJ GyvesE AllenA
McLeanDK PodolskyEvaluation of a serologic marker, CA19-9, in the
diagnosis of pancreatic cancerAnn Intern
Med110704709198910.7326/0003-4819-110-9-7042930108
|
|
5.
|
M AkdoganN SasmazB KayhanI BiyikogluS
DisibeyazB SahinExtraordinarily elevated CA19-9 in benign
conditions: a case report and review of the
literatureTumori87337339200111765186
|
|
6.
|
XG NiXF BaiYL MaoThe clinical value of
serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of
pancreatic cancerEur J Surg
Oncol31164169200510.1016/j.ejso.2004.09.00715698733
|
|
7.
|
E Petricoin IIILA LiottaCounterpoint: The
vision for a new diagnostic paradigmClin
Chem4912761278200310.1373/49.8.127612881442
|
|
8.
|
CJ ScarlettRC SmithA SaxbyProteomic
classification of pancreatic adenocarcinoma tissue using protein
chip
technologyGastroenterology13016701678200610.1053/j.gastro.2006.02.03616697731
|
|
9.
|
S BhattacharyyaER SiegelGM PetersenST
ChariLJ SuvaRS HaunDiagnosis of pancreatic cancer using serum
proteomic
profilingNeoplasia6674686200410.1593/neo.0426215548376
|
|
10.
|
J KoopmannZ ZhangN WhiteSerum diagnosis of
pancreatic adenocarcinoma using surface-enhanced laser desorption
and ionization mass spectrometryClin Cancer
Res10860868200410.1158/1078-0432.CCR-1167-3
|
|
11.
|
Y YuS ChenLS WangPrediction of pancreatic
cancer by serum biomarkers using surface-enhanced laser
desorption/ionization-based decision tree
classificationOncology687986200510.1159/000084824
|
|
12.
|
K HondaY HayashidaT UmakiPossible
detection of pancreatic cancer by plasma protein profilingCancer
Res651061310622200510.1158/0008-5472.CAN-05-185116288055
|
|
13.
|
M EhmannK FelixD HartmannIdentification of
potential markers for the detection of pancreatic cancer through
comparative serum protein expression
profilingPancreas34205214200710.1097/01.mpa.0000250128.57026.b217312459
|
|
14.
|
J SongM PatelCN RosenzweigQuantification
of fragments of human serum inter-alpha-trypsin inhibitor heavy
chain 4 by a surface-enhanced laser desorption/ionization-based
immunoassayClin Chem5210451053200610.1373/clinchem.2005.065722
|
|
15.
|
M DongY NioK TamuraKi-ras point mutation
and p53 expression in human pancreatic cancer: a comparative study
among Chinese, Japanese, and Western patientsCancer Epidemiol
Biomarkers Prev9279284200010750666
|
|
16.
|
P HeHZ HeJ DaiThe human plasma proteome:
analysis of Chinese serum using shotgun
strategyProteomics534423453200510.1002/pmic.20040130116047309
|
|
17.
|
JX WangJK YuL WangQL LiuJ ZhangS
ZhengApplication of serum protein fingerprint in diagnosis of
papillary thyroid
carcinomaProteomics653445349200610.1002/pmic.20050083316941571
|
|
18.
|
KA BaggerlyJS MorrisKR
CoombesReproducibility of SELDI-TOF protein patterns in serum:
comparing datasets from different
experimentsBioinformatics20777785200410.1093/bioinformatics/btg48414751995
|
|
19.
|
S BraunFD VoglB NaumeA pooled analysis of
bone marrow micrometastasis in breast cancerN Engl J
Med353793802200510.1056/NEJMoa05043416120859
|
|
20.
|
T SingO SanderN BeerenwinkelT
LengauerROCR: visualizing classifier performance in
RBioinformatics2139403941200510.1093/bioinformatics/bti62316096348
|
|
21.
|
P PavlidisI WapinskiWS NobleSupport vector
machine classification on the
webBioinformatics20586587200410.1093/bioinformatics/btg46114990457
|
|
22.
|
M WagnerDN NaikA PothenComputational
protein biomarker prediction: a case study for prostate cancerBMC
Bioinformatics526200410.1186/1471-2105-5-2615113409
|
|
23.
|
NT ZinkinF GrallK BhaskarSerum proteomics
and biomarkers in hepatocellular carcinoma and chronic liver
diseaseClin Cancer
Res14470477200810.1158/1078-0432.CCR-07-058618223221
|
|
24.
|
C RostyL ChristaS KuzdzalIdentification of
hepato-carcinoma-intestine-pancreas/pancreatitis-associated protein
I as a biomarker for pancreatic ductal adenocarcinoma by protein
biochip technologyCancer Res62186818752002
|
|
25.
|
C MelleG ErnstN EscherProtein profiling of
microdissected pancreas carcinoma and identification of HSP27 as a
potential serum markerClin
Chem53629635200710.1373/clinchem.2006.07919417303689
|
|
26.
|
EF PetricoinAM ArdekaniBA HittUse of
proteomic patterns in serum to identify ovarian
cancerLancet359572577200210.1016/S0140-6736(02)07746-211867112
|
|
27.
|
BL AdamY QuJW DavisSerum protein
fingerprinting coupled with a pattern-matching algorithm
distinguishes prostate cancer from benign prostate hyperplasia and
healthy menCancer Res62360936142002
|
|
28.
|
AJ RaiPM StemmerZ ZhangAnalysis of Human
Proteome Organization Plasma Proteome Project (HUPO PPP) reference
specimens using surface enhanced laser desorption/ionization-time
of flight (SELDI-TOF) mass spectrometry: multi-institution
correlation of spectra and identification of
biomarkersProteomics5346734742005
|
|
29.
|
OJ SemmesZ FengBL AdamEvaluation of serum
protein profiling by surface-enhanced laser desorption/ionization
time-of-flight mass spectrometry for the detection of prostate
cancer: I. Assessment of platform reproducibilityClin
Chem51102112200510.1373/clinchem.2004.038950
|
|
30.
|
M AivadoD SpentzosG AlterovitzOptimization
and evaluation of surface-enhanced laser desorption/ionization
time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase
protein arrays for protein profilingClin Chem Lab
Med43133140200510.1515/CCLM.2005.022
|
|
31.
|
DG WardY ChengG N’KontchouChanges in the
serum proteome associated with the development of hepatocellular
carcinoma in hepatitis C-related cirrhosisBr J
Cancer94287292200610.1038/sj.bjc.660292316404431
|
|
32.
|
J AlbrethsenR BogeboJ OlsenH RaskovS
GammeltoftPreanalytical and analytical variation of
surface-enhanced laser desorption-ionization time-of-flight mass
spectrometry of human serumClin Chem Lab
Med4412431252200610.1515/CCLM.2006.22817032137
|
|
33.
|
DG WardY ChengG N’KontchouPreclinical and
post-treatment changes in the HCC-associated serum proteomeBr J
Cancer9513791383200610.1038/sj.bjc.660342917060939
|
|
34.
|
J RobozMass spectrometry in diagnostic
oncoproteomicsCancer
Invest23465478200510.1081/CNV-6718216193645
|
|
35.
|
MP EbertJ MeuerJC WiemerIdentification of
gastric cancer patients by serum protein profilingJ Proteome
Res312611266200410.1021/pr049865s15595736
|
|
36.
|
GL HortinThe MALDI-TOF mass spectrometric
view of the plasma proteome and peptidomeClin
Chem5212231237200610.1373/clinchem.2006.06925216644871
|
|
37.
|
EF PetricoinLA LiottaSELDI-TOF-based serum
proteomic pattern diagnostics for early detection of cancerCurr
Opin Biotechnol152430200410.1016/j.copbio.2004.01.00515102462
|
|
38.
|
EE SchweglerL CazaresLF SteelSELDI-TOF MS
profiling of serum for detection of the progression of chronic
hepatitis C to hepatocellular
carcinomaHepatology41634642200510.1002/hep.2057715726646
|
